Literature DB >> 19333250

Anti-drug vaccines to treat substance abuse.

Berma M Kinsey1, David C Jackson, Frank M Orson.   

Abstract

Substance abuse is a growing world-wide problem. The big four drugs of abuse that might lend themselves to immunotherapy are nicotine, cocaine, morphine/heroin and methamphetamine. Tobacco abuse has a well-known enormous impact on major chronic cardiovascular and pulmonary diseases, while the last three, aside from their neuropsychological effects, are illegal, leading to crime and incarceration as well as the transmission of viral diseases. Having an efficient vaccine that would generate antibodies to sequester the drug and prevent its access to the brain could go a long way toward helping a motivated addict quit the addiction. This review will discuss what has been done to bring such vaccines to human use, and what the challenges are for the future of this promising intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333250     DOI: 10.1038/icb.2009.17

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  29 in total

Review 1.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

3.  Methamphetamine Vaccines: Improvement through Hapten Design.

Authors:  Karen C Collins; Joel E Schlosburg; Paul T Bremer; Kim D Janda
Journal:  J Med Chem       Date:  2016-04-19       Impact factor: 7.446

4.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

5.  Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors:  Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

6.  An antidote for acute cocaine toxicity.

Authors:  Jennifer B Treweek; Kim D Janda
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

Review 7.  Adjuvants for vaccines to drugs of abuse and addiction.

Authors:  Carl R Alving; Gary R Matyas; Oscar Torres; Rashmi Jalah; Zoltan Beck
Journal:  Vaccine       Date:  2014-08-08       Impact factor: 3.641

8.  Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.

Authors:  Martin J Hicks; Bishnu P De; Jonathan B Rosenberg; Jesse T Davidson; Amira Y Moreno; Kim D Janda; Sunmee Wee; George F Koob; Neil R Hackett; Stephen M Kaminsky; Stefan Worgall; Miklos Toth; Jason G Mezey; Ronald G Crystal
Journal:  Mol Ther       Date:  2011-01-04       Impact factor: 11.454

9.  Lipid tucaresol as an adjuvant for methamphetamine vaccine development.

Authors:  K C Collins; J E Schlosburg; J W Lockner; P T Bremer; B A Ellis; K D Janda
Journal:  Chem Commun (Camb)       Date:  2014-04-21       Impact factor: 6.222

10.  Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.

Authors:  Jonathan B Rosenberg; Bishnu P De; Martin J Hicks; Kim D Janda; Stephen M Kaminsky; Stefan Worgall; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.